Real-time enrollment status for this dlbcl clinical trial
Current Status
Recruiting
Checked: September 1, 2026 at 1:13 PM UTC
| NCT Number | NCT04792489 |
| Recruiting Status | Recruiting |
| Condition | DLBCL |
| Phase | PHASE2 |
| Target Enrollment | 315 participants |
| Active Locations | 30 sites in the US |
| Sponsor | Miltenyi Biomedicine GmbH |
| Last Updated on CT.gov | July 13, 2026 (Jul 13, 2026) |
As of September 1, 2026: Clinical trial NCT04792489 is currently recruiting participants. This phase2 study for dlbcl is actively seeking new participants at 30 locations across the United States. The study is sponsored by Miltenyi Biomedicine GmbH. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT04792489 is actively recruiting participants as of September 1, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 30 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT04792489 was last updated Jul 13, 2026 (July 13, 2026). HelloStudys verifies this status automatically.